Fig. 5From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinomaConstruction and evaluation of a nomogram. ROC curves, for DFS at A 1Â year, B 3Â years, C 5Â years, represent the sensitivity and specificity of a 19-ARG signature and the selected clinical features in predicting the prognosis of PRAD patients. D A nomogram for predicting DFS possibilities of PRAD patients. E Calibration plots revealed the agreement between the predicted outcomes and actual disease-free survival at 1, 3, and 5Â years in the TCGA-PRAD cohort. F ROC curves, for DFS at 1, 3, and 5Â years, represent the sensitivity and specificity of a nomogramBack to article page